197 related articles for article (PubMed ID: 22974822)
1. Cytokine mucosal expression in ulcerative colitis, the relationship between cytokine release and disease activity.
Pearl DS; Shah K; Whittaker MA; Nitch-Smith H; Brown JF; Shute JK; Trebble TM
J Crohns Colitis; 2013 Jul; 7(6):481-9. PubMed ID: 22974822
[TBL] [Abstract][Full Text] [Related]
2. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
[TBL] [Abstract][Full Text] [Related]
3. Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis.
Rismo R; Olsen T; Cui G; Christiansen I; Florholmen J; Goll R
Scand J Gastroenterol; 2012 May; 47(5):538-47. PubMed ID: 22486187
[TBL] [Abstract][Full Text] [Related]
4. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis.
Tsukada Y; Nakamura T; Iimura M; Iizuka BE; Hayashi N
Am J Gastroenterol; 2002 Nov; 97(11):2820-8. PubMed ID: 12425554
[TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of mucosal beta-defensin-2, TNFalpha and IL-1beta in ulcerative colitis].
Chang YY; Ouyang Q
Zhonghua Nei Ke Za Zhi; 2008 Jan; 47(1):11-4. PubMed ID: 18346318
[TBL] [Abstract][Full Text] [Related]
6. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
7. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
[TBL] [Abstract][Full Text] [Related]
8. Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis.
Iboshi Y; Nakamura K; Fukaura K; Iwasa T; Ogino H; Sumida Y; Ihara E; Akiho H; Harada N; Nakamuta M
J Gastroenterol; 2017 Mar; 52(3):315-326. PubMed ID: 27178567
[TBL] [Abstract][Full Text] [Related]
9. Impact of smoking cigarette on the mRNA expression of cytokines in mucosa of inflammatory bowel disease.
Vrablicova Z; Soltys K; Krajcovicova A; Stuchlikova K; Sturdik I; Koller T; Huorka M; Payer J; Killinger Z; Jackuliak P; Tkacik M; Stuchlik S; Sekac J; Hlavaty T
Physiol Res; 2019 Nov; 68(Suppl 2):S183-S192. PubMed ID: 31842582
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: correlation with disease activity.
Inoue S; Matsumoto T; Iida M; Mizuno M; Kuroki F; Hoshika K; Shimizu M
Am J Gastroenterol; 1999 Sep; 94(9):2441-6. PubMed ID: 10484006
[TBL] [Abstract][Full Text] [Related]
11. Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis.
Ishiguro Y
J Gastroenterol; 1999 Feb; 34(1):66-74. PubMed ID: 10204613
[TBL] [Abstract][Full Text] [Related]
12. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
Wang ZL; Wang YD; Wang K; Li JA; Li L
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
[TBL] [Abstract][Full Text] [Related]
13. MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis.
Haga K; Chiba A; Shibuya T; Osada T; Ishikawa D; Kodani T; Nomura O; Watanabe S; Miyake S
J Gastroenterol Hepatol; 2016 May; 31(5):965-72. PubMed ID: 26590105
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Cytokine and Efflux Transporter Expression in Pediatric Versus Adult-onset Ulcerative Colitis.
Savić Mlakar A; Hojsak I; Jergović M; Vojvoda Parčina V; Babić Ž; Troskot B; Mihaljević Ž; Bendelja K
J Pediatr Gastroenterol Nutr; 2017 Jun; 64(6):943-948. PubMed ID: 27622899
[TBL] [Abstract][Full Text] [Related]
15. Serum IL-17A in newly diagnosed treatment-naive patients with ulcerative colitis reflects clinical disease severity and predicts the course of disease.
Ohman L; Dahlén R; Isaksson S; Sjöling A; Wick MJ; Sjövall H; Van Oudenhove L; Simrén M; Strid H
Inflamm Bowel Dis; 2013 Oct; 19(11):2433-9. PubMed ID: 23966065
[TBL] [Abstract][Full Text] [Related]
16. Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis.
Frieri G; Giacomelli R; Pimpo M; Palumbo G; Passacantando A; Pantaleoni G; Caprilli R
Gut; 2000 Sep; 47(3):410-4. PubMed ID: 10940280
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis.
Dubois-Camacho K; Diaz-Jimenez D; De la Fuente M; Quera R; Simian D; Martínez M; Landskron G; Olivares-Morales M; Cidlowski JA; Xu X; Gao G; Xie J; Chnaiderman J; Soto-Rifo R; González MJ; Calixto A; Hermoso MA
Front Immunol; 2019; 10():2449. PubMed ID: 31824476
[TBL] [Abstract][Full Text] [Related]
18. Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity.
Pearl DS; Masoodi M; Eiden M; Brümmer J; Gullick D; McKeever TM; Whittaker MA; Nitch-Smith H; Brown JF; Shute JK; Mills G; Calder PC; Trebble TM
J Crohns Colitis; 2014 Jan; 8(1):70-9. PubMed ID: 23619007
[TBL] [Abstract][Full Text] [Related]
19. Study of cytokines in ulcerative colitis.
Funakoshi K; Sugimura K; Sasakawa T; Bannai H; Anezaki K; Ishizuka K; Yoshida K; Narisawa R; Asakura H
J Gastroenterol; 1995 Nov; 30 Suppl 8():61-3. PubMed ID: 8563893
[TBL] [Abstract][Full Text] [Related]
20. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]